A Study To Assess The Safety And Tolerability Of Different Doses Of PF-06444753 And PF-06444752 In Subjects With Allergic Rhinitis

NCT01723254 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
190
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer